1. Home
  2. TECX vs OOMA Comparison

TECX vs OOMA Comparison

Compare TECX & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • OOMA
  • Stock Information
  • Founded
  • TECX 2019
  • OOMA 2003
  • Country
  • TECX United States
  • OOMA United States
  • Employees
  • TECX N/A
  • OOMA N/A
  • Industry
  • TECX
  • OOMA EDP Services
  • Sector
  • TECX
  • OOMA Technology
  • Exchange
  • TECX Nasdaq
  • OOMA Nasdaq
  • Market Cap
  • TECX 387.1M
  • OOMA 345.3M
  • IPO Year
  • TECX 2018
  • OOMA 2015
  • Fundamental
  • Price
  • TECX $16.01
  • OOMA $12.71
  • Analyst Decision
  • TECX Buy
  • OOMA Strong Buy
  • Analyst Count
  • TECX 6
  • OOMA 5
  • Target Price
  • TECX $79.17
  • OOMA $17.63
  • AVG Volume (30 Days)
  • TECX 475.2K
  • OOMA 191.0K
  • Earning Date
  • TECX 11-06-2025
  • OOMA 08-26-2025
  • Dividend Yield
  • TECX N/A
  • OOMA N/A
  • EPS Growth
  • TECX N/A
  • OOMA N/A
  • EPS
  • TECX N/A
  • OOMA N/A
  • Revenue
  • TECX N/A
  • OOMA $261,617,000.00
  • Revenue This Year
  • TECX N/A
  • OOMA $6.33
  • Revenue Next Year
  • TECX N/A
  • OOMA $6.15
  • P/E Ratio
  • TECX N/A
  • OOMA N/A
  • Revenue Growth
  • TECX N/A
  • OOMA 5.42
  • 52 Week Low
  • TECX $13.70
  • OOMA $10.88
  • 52 Week High
  • TECX $61.07
  • OOMA $17.00
  • Technical
  • Relative Strength Index (RSI)
  • TECX 34.36
  • OOMA 52.25
  • Support Level
  • TECX $15.92
  • OOMA N/A
  • Resistance Level
  • TECX $18.61
  • OOMA $12.83
  • Average True Range (ATR)
  • TECX 1.58
  • OOMA 0.38
  • MACD
  • TECX -0.46
  • OOMA -0.48
  • Stochastic Oscillator
  • TECX 5.59
  • OOMA 94.15

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

Share on Social Networks: